Retigeric acid B exhibits antitumor activity through suppression of nuclear factor-κB signaling in prostate cancer cells in vitro and in vivo.
about
Imbricaric acid and perlatolic acid: multi-targeting anti-inflammatory depsides from Cetrelia monachorumDifferential regulation of MMPs by E2F1, Sp1 and NF-kappa B controls the small cell lung cancer invasive phenotypeCrosstalk between apoptosis and autophagy: molecular mechanisms and therapeutic strategies in cancer.Beyond cell death - antiapoptotic Bcl-2 proteins regulate migration and invasion of colorectal cancer cells in vitroAn antioxidant extract of tropical lichen, Parmotrema reticulatum, induces cell cycle arrest and apoptosis in breast carcinoma cell line MCF-7Ixeris dentata (Thunb. Ex Thunb.) Nakai Extract Inhibits Proliferation and Induces Apoptosis in Breast Cancer Cells through Akt/NF-κB Pathways.Retigeric acid B-induced mitophagy by oxidative stress attenuates cell death against prostate cancer cells in vitro.Increased Intracellular Reactive Oxygen Species Mediates the Anti-Cancer Effects of WZ35 via Activating Mitochondrial Apoptosis Pathway in Prostate Cancer Cells.Malformin A1 promotes cell death through induction of apoptosis, necrosis and autophagy in prostate cancer cells.TNF receptor-associated factor 6 regulates proliferation, apoptosis, and invasion of glioma cells.Elevated serine protease HtrA1 inhibits cell proliferation, reduces invasion, and induces apoptosis in esophageal squamous cell carcinoma by blocking the nuclear factor-κB signaling pathway.Effect of TRAF6 on the biological behavior of human lung adenocarcinoma cell.Enhancement of cisplatin cytotoxicity by Retigeric acid B involves blocking DNA repair and activating DR5 in prostate cancer cells.
P2860
Q21132474-C177A94C-B2ED-4B7A-87BE-C7F8E56CB43DQ33828483-DF9FDDCD-8C94-46E0-ACBF-DF6EDDD2AC82Q34102626-50C2A648-C71C-4122-AC26-AC9103CF7F68Q35009440-55CC378D-2F89-4E06-B88E-7FF0C4875BF6Q35072698-0CD3EDA3-3023-4500-AAC4-81A5BD89CF35Q37690703-E0352752-3020-46A6-8EC9-A62E2E49228BQ37729583-B6A59061-7008-4755-BBCF-82967A272B81Q38725529-AB2938E6-D543-448F-9F11-55E74F80190FQ38813756-3B090C2F-DA82-4E81-8451-6403AD984034Q39202910-EC393B07-3F51-4372-9BDD-AA1BD3F67A2EQ39256693-1873FC5E-54B6-4A17-A4F8-82D6486ABE2FQ39261869-FCF9D158-ECAA-46E4-B1BF-EF910D037FC7Q49479651-B54CE33E-5FF4-44BF-B9B2-10753A587244
P2860
Retigeric acid B exhibits antitumor activity through suppression of nuclear factor-κB signaling in prostate cancer cells in vitro and in vivo.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Retigeric acid B exhibits anti ...... er cells in vitro and in vivo.
@ast
Retigeric acid B exhibits anti ...... er cells in vitro and in vivo.
@en
Retigeric acid B exhibits anti ...... er cells in vitro and in vivo.
@nl
type
label
Retigeric acid B exhibits anti ...... er cells in vitro and in vivo.
@ast
Retigeric acid B exhibits anti ...... er cells in vitro and in vivo.
@en
Retigeric acid B exhibits anti ...... er cells in vitro and in vivo.
@nl
prefLabel
Retigeric acid B exhibits anti ...... er cells in vitro and in vivo.
@ast
Retigeric acid B exhibits anti ...... er cells in vitro and in vivo.
@en
Retigeric acid B exhibits anti ...... er cells in vitro and in vivo.
@nl
P2093
P2860
P1433
P1476
Retigeric acid B exhibits anti ...... er cells in vitro and in vivo.
@en
P2093
Charles Y F Young
Hong-Xiang Lou
Hui-Qing Yuan
Xiao-Yan Hu
Yan-Na Cheng
Yong-Qing Liu
P2860
P304
P356
10.1371/JOURNAL.PONE.0038000
P407
P577
2012-05-29T00:00:00Z